PersonalSoft SAS – Trademark Portfolio

Entity Type: 99

PersonalSoft SAS holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include PERSONAL SOFT. The owner is based in Medellin, Antioquia.

Centro Empresarial Ciudad del Rio C2

Medellin, Antioquia Oficina10 , CO

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

PersonalSoft SAS's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (3 filings)

Scientific and technological services; industrial analysis and research services

35
Advertising & Business (2 filings)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does PersonalSoft SAS have?

PersonalSoft SAS has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending, 1 abandoned.

What trademark classes does PersonalSoft SAS file in?

PersonalSoft SAS files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business). Class 42 covers scientific and technological services; industrial analysis and research services.

What are PersonalSoft SAS's most well-known trademarks?

PersonalSoft SAS's registered trademark portfolio includes well-known marks such as PERSONAL SOFT. These are among 1 currently registered trademark in the portfolio.

What is PersonalSoft SAS's trademark registration success rate?

PersonalSoft SAS has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 1 application is pending review.